id	keyword
cblr-1723	proposal
cblr-1723	shareholder
cblr-1723	company
cblr-1723	pricing
cblr-1723	business
cblr-1723	price
cblr-1723	supra
cblr-1723	sec
cblr-1723	pharmaceutical
cblr-1723	note
cblr-1723	ret
cblr-1723	action
cblr-1723	goeman
cblr-1723	proxy
cblr-1723	drug
cblr-1723	sys
cblr-1723	shareholder proposals
cblr-1723	letter
cblr-1723	companies
cblr-1723	investors
cblr-1723	supra note
cblr-1723	review
cblr-1723	section
cblr-1723	law
cblr-1723	board
cblr-1723	state
cblr-1723	policies
cblr-1723	policy
cblr-1723	exclusion
cblr-1723	gilead
cblr-1723	rule